UK markets closed
NIKKEI 225
38,405.66 +470.90 (+1.24%) HANG SENG
17,763.03 +16.12 (+0.09%) CRUDE OIL
81.74 -0.89 (-1.08%) GOLD FUTURES
2,303.10 -54.60 (-2.32%) DOW
37,941.09 -445.00 (-1.16%) Bitcoin GBP
47,962.43 -2,148.98 (-4.29%)
NVO Jan 2025 140.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 11:59AM EDT. Market open.
Loading interactive chart…
- Yahoo Finance
Eli Lilly reports $2 billion from Mounjaro, Zepbound in Q1 2024
Eli Lilly missed on total sales in the first quarter, but its GLP-1 drugs helped boost sales by 26% over those in Q1 2023.
- Investor's Business Daily
IBD Stock Of The Day Eli Lilly Surges After Weight-Loss Drug Obliterates Sales Views
Eli Lilly stock jumped Tuesday despite a mixed first-quarter report, after sales of weight-loss drug Zepbound obliterated expectations.
- Zacks
Eli Lilly (LLY) Q1 Earnings Top, Sales Miss, 2024 View Raised
Eli Lilly (LLY) beats first-quarter estimates for earnings but misses the same for sales. It raises its guidance for 2024 on strong demand for Mounjaro and Zepbound.
© 2024 Yahoo. All rights reserved.